This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Sandbox Reserved 1073
From Proteopedia
(Difference between revisions)
| Line 5: | Line 5: | ||
== Introduction == | == Introduction == | ||
| - | The Enoyl-ACP Reductase InhA, from ''Mycobacterium tuberculosis'', catalyzes the NADH-dependent reduction of long-chain ''trans''-2-enoyl-ACP fatty acids in the type II fatty acid biosynthesis pathway of ''M.'' ''tuberculosis''. InhA is a member of the [http://en.wikipedia.org/wiki/Short-chain_dehydrogenase short chain dehydrogenase/reductase] (SDR) family of enzymes. | + | The Enoyl-ACP Reductase InhA, from ''Mycobacterium tuberculosis'', catalyzes the [http://en.wikipedia.org/wiki/Nicotinamide_adenine_dinucleotide NADH]-dependent reduction of long-chain ''trans''-2-enoyl-ACP fatty acids in the type II fatty acid biosynthesis pathway of ''M.'' ''tuberculosis''. InhA is a member of the [http://en.wikipedia.org/wiki/Short-chain_dehydrogenase short chain dehydrogenase/reductase] (SDR) family of enzymes. |
=== FAS-II System === | === FAS-II System === | ||
Revision as of 12:18, 31 March 2015
| This Sandbox is Reserved from 02/09/2015, through 05/31/2016 for use in the course "CH462: Biochemistry 2" taught by Geoffrey C. Hoops at the Butler University. This reservation includes Sandbox Reserved 1051 through Sandbox Reserved 1080. |
To get started:
More help: Help:Editing |
Enoyl-ACP Reductase InhA
| |||||||||||
